[go: up one dir, main page]

AR024959A1 - A LIQUID PHARMACEUTICAL COMPOSITION BASED ON PARACETAMOL - Google Patents

A LIQUID PHARMACEUTICAL COMPOSITION BASED ON PARACETAMOL

Info

Publication number
AR024959A1
AR024959A1 ARP000103883A ARP000103883A AR024959A1 AR 024959 A1 AR024959 A1 AR 024959A1 AR P000103883 A ARP000103883 A AR P000103883A AR P000103883 A ARP000103883 A AR P000103883A AR 024959 A1 AR024959 A1 AR 024959A1
Authority
AR
Argentina
Prior art keywords
paracetamol
liquid pharmaceutical
pharmaceutical composition
composition based
solution
Prior art date
Application number
ARP000103883A
Other languages
Spanish (es)
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of AR024959A1 publication Critical patent/AR024959A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Una forma de dosificacion farmacéutica líquida que consiste en una solucion, la cual comprende por lo menos el 10% (p/v) de paracetamol en PEG-200 anhidro.A liquid pharmaceutical dosage form consisting of a solution, which comprises at least 10% (w / v) paracetamol in anhydrous PEG-200.

ARP000103883A 1999-07-30 2000-07-27 A LIQUID PHARMACEUTICAL COMPOSITION BASED ON PARACETAMOL AR024959A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999MI001697A IT1313579B1 (en) 1999-07-30 1999-07-30 PARACETAMOL-BASED LIQUID PHARMACEUTICAL COMPOSITION.

Publications (1)

Publication Number Publication Date
AR024959A1 true AR024959A1 (en) 2002-10-30

Family

ID=11383451

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000103883A AR024959A1 (en) 1999-07-30 2000-07-27 A LIQUID PHARMACEUTICAL COMPOSITION BASED ON PARACETAMOL

Country Status (4)

Country Link
AR (1) AR024959A1 (en)
AU (1) AU6565100A (en)
IT (1) IT1313579B1 (en)
WO (1) WO2001008662A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2862872A1 (en) * 2003-12-02 2005-06-03 Palbian Snc AQUEOUS COMPOSITION FOR THE PERFUSABLE APPLICATION OF AN ACTIVE, PARTICULARLY PHARMACOLOGICAL PRINCIPLE SUCH AS PARACETAMOL
US9585849B2 (en) 2006-04-17 2017-03-07 The Burlington Hc Research Group, Inc. Broad spectrum antiviral and methods of use
EP1992334A1 (en) * 2007-05-08 2008-11-19 Docpharma NV/SA Storage-stable formulation of oxidation-sensitive phenolic drug, especially paracetamol, comprises aqueous drug solution deoxygenated by a temperature-controlled manufacturing process of the formulation
AU2008285244B2 (en) * 2007-08-07 2015-02-19 Stellenbosch University A medicament
EP2243477A1 (en) 2009-04-22 2010-10-27 Fresenius Kabi Deutschland GmbH Paracetamol for parenteral application
PE20130782A1 (en) * 2010-06-30 2013-06-20 Troikaa Pharmaceuticals Ltd PHARMACEUTICAL COMPOSITIONS CONSISTING OF PARACETAMOL AND THE PROCESS FOR THE PREPARATION OF THE SAME
IT1403660B1 (en) * 2011-01-28 2013-10-31 Abiogen Pharma Spa PHARMACEUTICAL COMPOSITION LIQUID CONTAINING PARACETAMOL
JP6539274B2 (en) 2013-08-12 2019-07-03 ファーマシューティカル マニュファクチュアリング リサーチ サービシズ,インコーポレーテッド Extruded immediate release abuse deterrent pills
US20150141518A1 (en) * 2013-11-21 2015-05-21 Emphascience, Inc. Water-miscible stable solution composition for pharmaceutically active ingredients that are poorly soluble in water and susceptible to chemical degradation
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
EP3169315B1 (en) 2014-07-17 2020-06-24 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
US20160106737A1 (en) 2014-10-20 2016-04-21 Pharmaceutical Manufacturing Research Services, Inc. Extended Release Abuse Deterrent Liquid Fill Dosage Form
US20160144033A1 (en) * 2014-11-21 2016-05-26 Emphascience, Inc. Concentrated acetaminophen solution
PE20171305A1 (en) 2014-12-20 2017-09-05 Troikaa Pharmaceuticals Ltd INJECTABLE FORMULATIONS OF PARACETAMOL
WO2025165315A1 (en) * 2024-01-29 2025-08-07 Bezmi̇alem Vakif Üni̇versi̇tesi̇ Paracetamol formulation for intranasal administration

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
US5505961A (en) * 1993-08-05 1996-04-09 R. P. Scherer Corporation Gelatin capsules containing a highly concentrated acetaminophen solution
US5510389A (en) * 1994-03-02 1996-04-23 The Procter & Gamble Company Concentrated acetaminophen solution compositions
FR2751875B1 (en) * 1996-08-05 1998-12-24 Scr Newpharm NOVEL STABLE LIQUID FORMULATIONS BASED ON PARACETAMOL AND THEIR METHOD OF PREPARATION

Also Published As

Publication number Publication date
IT1313579B1 (en) 2002-09-09
WO2001008662A1 (en) 2001-02-08
ITMI991697A0 (en) 1999-07-30
ITMI991697A1 (en) 2001-01-30
AU6565100A (en) 2001-02-19

Similar Documents

Publication Publication Date Title
AR024959A1 (en) A LIQUID PHARMACEUTICAL COMPOSITION BASED ON PARACETAMOL
PT1318791E (en) ISOTRETINOIN SEMI-SOLID PHARMACEUTICAL COMPOSITION
PA8509001A1 (en) DOSAGE FORM OF DRUGS DRIVEN BY A HYDROGEL
DE60019693D1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ACTIVE ABSORPTION-CONNECTING COMPOUNDS
ECSP003847A (en) PHARMACEUTICAL COMPOSITIONS THAT PROVIDE POWERFUL FARMACO CONCENTRATIONS
IL165601A0 (en) Oral pharmaceutical forms of liquid drugs having improved bioavailability
CO4290295A1 (en) MEDICATION IN THE FORM OF A TABLET WITH DELAYED RELEASE OF ACTIVE SUBSTANCE
MXPA02007915A (en) Aspirin triggered lipid mediators.
EA200000814A1 (en) PHARMACEUTICAL COMPOSITION TOPIRAMAT
DE60134245D1 (en) (5- (2-HYDROXY-4-CHLOROBENZOYL) VALERIANIC ACID AND ITS SALTS, AND COMPOSITIONS FOR ADDING ACTIVITIES CONTAINING THESE COMPOUNDS
ES2060825T3 (en) A THERAPEUTIC SYSTEM FOR DELAYED AND CONTROLLED ADMINISTRATION OF ACTIVE SUBSTANCES BY VIA PERCUTANEA OR THROUGH THE MUCOSA.
DK0695171T3 (en) Lyospheres containing gonadotropin
AR028727A1 (en) A LIQUID DETERGENT COMPOSITION
BR0013106A (en) Floating pharmaceutical composition, tablet, and tablet preparation process.
DE60223542D1 (en) COMPOSITION WITH FULVESTRANT
AR037131A1 (en) RIBAVIRINA SYRUP FORMULATIONS
AR034142A1 (en) A PHARMACEUTICAL COMPOSITION, METHOD FOR MANUFACTURING A MEDICINAL BASED ON SUCH COMPOSITION AND USE OF THE COMPOSITION
CO4950520A1 (en) PARENTERAL FORMULATIONS OF 5H-DIBENZ (B, F) AZEPIN-5- CARBOXIAMIDES USEFUL IN THE TREATMENT OF EPILEPTIC ATTACKS
UY26530A1 (en) COMPOSITION.
ATE338567T1 (en) PHARMACEUTICAL PREPARATIONS CONTAINING ACTIVE INGREDIENTS SUITABLE FOR UNAUTHORIZED ADMINISTRATION
ATE263547T1 (en) PHARMACEUTICAL MIXTURE CONTAINING A PROFENE AND OTHER ACTIVE SUBSTANCES
SE9902742D0 (en) New pharmaceutical formultion
ES2190581T3 (en) 2-OPTICALLY ACTIVE AMINOTETRALINE, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT, ACTIVE IN THE PREVENTION AND TREATMENT OF SEPTIC SHOCK.
IT1265647B1 (en) TOPICAL PHARMACEUTICAL COMPOSITION FOR RESPIRATORY ALLERGIES
EA200400382A1 (en) APPLICATION OF SPECIFIC DOSE OF SODIUM FONDAPARINUKS FOR THE TREATMENT OF OX